Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 3
2007 4
2008 4
2009 12
2010 1
2011 3
2012 2
2013 9
2014 4
2015 5
2016 6
2017 8
2018 13
2019 20
2020 10
2021 13
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Calciphylaxis.
Nigwekar SU, Thadhani R, Brandenburg VM. Nigwekar SU, et al. N Engl J Med. 2018 May 3;378(18):1704-1714. doi: 10.1056/NEJMra1505292. N Engl J Med. 2018. PMID: 29719190 Review. No abstract available.
Calciphylaxis: risk factors, diagnosis, and treatment.
Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM, Steele DJ, Thadhani RI. Nigwekar SU, et al. Am J Kidney Dis. 2015 Jul;66(1):133-46. doi: 10.1053/j.ajkd.2015.01.034. Epub 2015 May 7. Am J Kidney Dis. 2015. PMID: 25960299 Free PMC article. Review.
HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype.
Malhotra R, Mauer AC, Lino Cardenas CL, Guo X, Yao J, Zhang X, Wunderer F, Smith AV, Wong Q, Pechlivanis S, Hwang SJ, Wang J, Lu L, Nicholson CJ, Shelton G, Buswell MD, Barnes HJ, Sigurslid HH, Slocum C, Rourke CO, Rhee DK, Bagchi A, Nigwekar SU, Buys ES, Campbell CY, Harris T, Budoff M, Criqui MH, Rotter JI, Johnson AD, Song C, Franceschini N, Debette S, Hoffmann U, Kälsch H, Nöthen MM, Sigurdsson S, Freedman BI, Bowden DW, Jöckel KH, Moebus S, Erbel R, Feitosa MF, Gudnason V, Thanassoulis G, Zapol WM, Lindsay ME, Bloch DB, Post WS, O'Donnell CJ. Malhotra R, et al. Among authors: nigwekar su. Nat Genet. 2019 Nov;51(11):1580-1587. doi: 10.1038/s41588-019-0514-8. Epub 2019 Oct 28. Nat Genet. 2019. PMID: 31659325 Free PMC article.
Calciphylaxis.
Nigwekar SU, Thadhani R, Brandenburg VM. Nigwekar SU, et al. N Engl J Med. 2018 Jul 26;379(4):399-400. doi: 10.1056/NEJMc1807324. N Engl J Med. 2018. PMID: 30044942 No abstract available.
Calciphylaxis.
Nigwekar SU. Nigwekar SU. Curr Opin Nephrol Hypertens. 2017 Jul;26(4):276-281. doi: 10.1097/MNH.0000000000000328. Curr Opin Nephrol Hypertens. 2017. PMID: 28375870 Free PMC article. Review.
Revisiting therapeutic options for calciphylaxis.
Seethapathy H, Nigwekar SU. Seethapathy H, et al. Among authors: nigwekar su. Curr Opin Nephrol Hypertens. 2019 Sep;28(5):448-454. doi: 10.1097/MNH.0000000000000520. Curr Opin Nephrol Hypertens. 2019. PMID: 31169527 Review.
Calciphylaxis-as a drug induced adverse event.
Portales-Castillo I, Kroshinsky D, Malhotra CK, Culber-Costley R, Cozzolino MG, Karparis S, Halasz CL, Goverman J, Manley HJ, Malhotra R, Nigwekar SU. Portales-Castillo I, et al. Among authors: nigwekar su. Expert Opin Drug Saf. 2019 Jan;18(1):29-35. doi: 10.1080/14740338.2019.1559813. Epub 2018 Dec 24. Expert Opin Drug Saf. 2019. PMID: 30574812 Review.
Opioids in Hemodialysis Patients.
Kalim S, Lyons KS, Nigwekar SU. Kalim S, et al. Among authors: nigwekar su. Semin Nephrol. 2021 Jan;41(1):24-32. doi: 10.1016/j.semnephrol.2021.02.003. Semin Nephrol. 2021. PMID: 33896471 Free PMC article. Review.
106 results